The hCG assay or pregnancy test

被引:24
作者
Cole, Laurence A. [1 ]
机构
[1] Univ New Mexico, Dept Obstet & Gynecol, USA hCG Reference Serv, Albuquerque, NM 87131 USA
关键词
hCG; hCG test; hyperglycosylated hCG; pregnancy; pregnancy test; HUMAN CHORIONIC-GONADOTROPIN; INVASIVE TROPHOBLAST ANTIGEN; BETA-CORE FRAGMENT; HYPERGLYCOSYLATED HCG; PULSATILE SECRETION; SUBUNIT; EXPRESSION; APOPTOSIS; CANCER; CHORIOCARCINOMA;
D O I
10.1515/CCLM.2011.808
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
This review examines human chorionic gonadotropin (hCG) or pregnancy tests from multiple perspectives. It first investigates the molecule hCG and shows that the term represents five independent molecules differing in carbohydrate and meric structure that share a common amino acid sequence. The review goes on to show that multiple degradation produces also the need to be tested for an hCG or pregnancy test to be optimally efficient. The review then carefully examines the literature showing the sensitivity and specificity of automated laboratory tests. Point-of-care pregnancy tests are then investigated along with over-the-counter pregnancy tests. Appropriate detection of hyperglycosylated hCG, nicked hCG, nicked hCG missing the beta-subunit C-terminal peptide and nicked hyperglycosylated hCG is a limitation on all pregnancy tests. In the opinion of the author, just one automated laboratory test, the Siemen's Immulite, one point-of-care test, the Beckman-Coulter Icon 25, and one brand of over-the-counter device, First Response, are suitable for early pregnancy detection and possibly other applications.
引用
收藏
页码:617 / 630
页数:14
相关论文
共 60 条
  • [1] Acevedo HF, 1996, CANCER, V78, P2388, DOI 10.1002/(SICI)1097-0142(19961201)78:11<2388::AID-CNCR18>3.0.CO
  • [2] 2-X
  • [3] Bellet D, 1997, CANCER RES, V57, P516
  • [4] CHARACTERIZATION OF A CLEAVAGE PRODUCT IN THE HUMAN CHORIO-GONADOTROPIN BETA-SUBUNIT
    BIDART, JM
    PUISIEUX, A
    TROALEN, F
    FOGLIETTI, MJ
    BOHUON, C
    BELLET, D
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 154 (02) : 626 - 632
  • [5] Isolation and characterization of human pituitary chorionic gonadotropin
    Birken, S
    Maydelman, Y
    Gawinowicz, MA
    Pound, A
    Liu, YP
    Hartree, AS
    [J]. ENDOCRINOLOGY, 1996, 137 (04) : 1402 - 1411
  • [6] THE HETEROGENEITY OF HUMAN CHORIONIC-GONADOTROPIN (HCG) .2. CHARACTERISTICS AND ORIGINS OF NICKS IN HCG REFERENCE-STANDARDS
    BIRKEN, S
    GAWINOWICZ, MA
    KARDANA, A
    COLE, LA
    [J]. ENDOCRINOLOGY, 1991, 129 (03) : 1551 - 1558
  • [7] Butler SA, 2000, BRIT J CANCER, V82, P1553
  • [8] Butler SA, 2003, CLIN CANCER RES, V9, P4666
  • [9] Butler SA, 2010, HUMAN CHORIONIC GONADOTROPIN (HCG), P153, DOI 10.1016/B978-0-12-384907-6.00014-1
  • [10] Carter WB, 2006, BREAST CANCER RES TR, V100, pS243